238 related articles for article (PubMed ID: 12750918)
21. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?
Dobrzycki S; Baniukiewicz A; Korecki J; Bachórzewska-Gajewska H; Prokopczuk P; Musial WJ; Kamiński KA; Dabrowski A
Int J Cardiol; 2005 Sep; 104(1):67-72. PubMed ID: 16137512
[TBL] [Abstract][Full Text] [Related]
22. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
[TBL] [Abstract][Full Text] [Related]
23. Is ambulatory 24-h dual-probe pH monitoring useful in suspected ENT manifestations of GERD?
Sermon F; Vanden Brande S; Roosens B; Mana F; Deron P; Urbain D
Dig Liver Dis; 2004 Feb; 36(2):105-10. PubMed ID: 15002816
[TBL] [Abstract][Full Text] [Related]
24. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
25. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
26. Potential relationship between gastroesophageal reflux disease and atrial arrhythmias.
Gerson LB; Friday K; Triadafilopoulos G
J Clin Gastroenterol; 2006 Oct; 40(9):828-32. PubMed ID: 17016140
[TBL] [Abstract][Full Text] [Related]
27. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
[TBL] [Abstract][Full Text] [Related]
28. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
29. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
[TBL] [Abstract][Full Text] [Related]
30. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
Bilgen C; Ogüt F; Kesimli-Dinç H; Kirazli T; Bor S
J Laryngol Otol; 2003 May; 117(5):386-90. PubMed ID: 12803789
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea.
Cho YS; Choi MG; Jeong JJ; Chung WC; Lee IS; Kim SW; Han SW; Choi KY; Chung IS
Am J Gastroenterol; 2005 Apr; 100(4):747-53. PubMed ID: 15784014
[TBL] [Abstract][Full Text] [Related]
32. Relationship between globus sensation and esophageal clearance.
Adachi J; Ohmae Y; Karaho T; Tanabe T; Mizokami D; Hirota K; Tomifuji M; Kurita A; Matsunobu T; Shiotani A
Acta Otolaryngol; 2010; 130(1):138-44. PubMed ID: 19449225
[TBL] [Abstract][Full Text] [Related]
33. [Gastroesophageal reflux and laryngopharyngeal disorders: pH-metric essay of the acid exposure of the proximal and distal esophagus].
Longhini A; Franzini M; Kazemian AR; Munarini G; Marcolli G
Minerva Chir; 2004 Aug; 59(4):337-45. PubMed ID: 15278028
[TBL] [Abstract][Full Text] [Related]
34. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
35. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
Bishop J; Furman M; Thomson M
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
[TBL] [Abstract][Full Text] [Related]
36. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
[TBL] [Abstract][Full Text] [Related]
37. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
[TBL] [Abstract][Full Text] [Related]
38. Should upper gastrointestinal endoscopy be part of the evaluation for supraesophageal symptoms of GERD?
DeVault KR
Am J Gastroenterol; 2004 Aug; 99(8):1427-9. PubMed ID: 15307854
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
40. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
Malhotra A; Freston JW; Aziz K
J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]